Stem cell advance may assist new therapies for anemia, leukemia

Scientists at the Scripps Research Institute say they've identified an enzyme necessary for maintaining the stability of hematopoietic stem cells. The advance with Inositol trisphosphate 3-kinase B (ItpkB) is being billed as an important step forward in "improving therapies for diseases such as bone marrow failure syndrome, anemia, leukemia, lymphoma and immunodeficiencies." Release